Industry Research Reports

Home > Reports > Service & Software > Global Spatial Proteomics and Transcriptomics Services Market Research Report 2026

Global Spatial Proteomics and Transcriptomics Services Market Research Report 2026

Industry: Service & Software

Published Date: 2026-07-17

Pages: 187 Pages

Report ld: 6977578

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Spatial Proteomics and Transcriptomics Services Market Size(US$)

CAGR 2026-2032

14.4%

Market Size,2032

USD 470

Million

Market Snapshot

Market Size in 2026 (Value)

US$ 210 million

Market Forecast in 2032(Value)

US$ 470 million

CAGR

14.4%

Years Considered

2021-2032

Base Year

2026

Forecast Period

2026-2032

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Spatial Proteomics and Transcriptomics Services market was valued at US$ 188 million in 2025 and is anticipated to reach US$ 470 million by 2032, at a CAGR of 14.4% from 2026 to 2032.

Spatial Proteomics and Transcriptomics Services refer to specialized research services that integrate spatial biology technologies to simultaneously characterize RNA expression patterns and protein expression profiles while preserving the original spatial architecture of tissues and cells. By combining spatial transcriptomic and spatial proteomic information with advanced bioinformatics analysis, these services enable multidimensional investigation of gene regulation, protein function, cellular interactions, and tissue microenvironment.

Unlike conventional transcriptomics or proteomics approaches that analyze molecular changes from bulk samples, spatial proteomics and transcriptomics services provide answers to critical biological questions including which genes and proteins are altered, which cells express these molecules, where they are located within tissues, and how different cellular populations interact within biological environments.

These services typically integrate spatial transcriptomics platforms, spatial protein detection technologies, single-cell analysis, high-resolution imaging systems, and artificial intelligence-based spatial data analytics. Major technology platforms include 10x Genomics Visium/Xenium, Vizgen MERSCOPE MERFISH, NanoString/Bruker GeoMx DSP, Akoya PhenoCycler-Fusion, and Standard BioTools Hyperion Imaging Mass Cytometry. They provide end-to-end solutions covering sample preparation, spatial profiling, computational analysis, and biological interpretation. (vizgen.com)

Spatial Proteomics and Transcriptomics Services are widely applied in oncology, immunotherapy, precision medicine, drug mechanism studies, disease classification, biomarker discovery, and pharmaceutical development.

Spatial Proteomics and Transcriptomics Services primarily operate under a technology-intensive CRO model combining advanced spatial omics platforms, specialized laboratory expertise, and bioinformatics capabilities. Service providers establish comprehensive spatial biology infrastructure, including tissue processing systems, spatial RNA profiling platforms, spatial protein detection technologies, high-resolution imaging systems, mass spectrometry platforms, and computational analysis pipelines.

Typical workflows include project design, sample quality assessment, tissue preparation, spatial probe or antibody labeling, spatial signal acquisition, sequencing or imaging analysis, cell-type identification, spatial clustering, multi-omics integration, and biological reporting.

The industry value chain includes upstream suppliers of spatial omics instruments, sequencing platforms, mass spectrometry systems, imaging technologies, spatial probes, antibodies, and bioinformatics software. The midstream sector consists of spatial multi-omics CRO providers, life science service companies, and research technology platforms. Downstream customers include pharmaceutical companies, biotechnology companies, academic institutions, hospitals, and precision medicine organizations.

Due to high instrument investment, specialized expertise, and complex computational requirements, spatial proteomics and transcriptomics services represent a high-value-added research segment. Standardized spatial transcriptomics services generally achieve gross margins of approximately 40%-60%. Advanced integrated spatial proteomics-transcriptomics projects, multi-omics analysis, and pharmaceutical discovery applications may achieve margins of 55%-75%. Companies with proprietary algorithms, databases, automated workflows, and pharmaceutical partnerships may achieve margins approaching 70%.

Spatial Proteomics and Transcriptomics Services are becoming a strategic growth area in life science research and innovative drug discovery. As precision medicine evolves from conventional molecular profiling toward spatially resolved, single-cell, and integrated biological analysis, demand for understanding tissue microenvironments, cellular heterogeneity, and molecular interactions continues to increase.

Spatial multi-omics provides both RNA expression information and protein functional information, creating significant value in immuno-oncology, targeted drug development, biomarker discovery, and patient stratification. Advances in AI-based image analysis, high-throughput spatial profiling platforms, and multi-omics databases will further enhance the commercial value of these services.

The spatial proteomics and transcriptomics service market faces challenges including high equipment investment, complex workflows, limited analytical standardization, and relatively long clinical translation cycles. The field requires integration of histology, molecular detection, imaging, sequencing, and artificial intelligence technologies, creating high capability barriers.

Data interoperability among platforms, standardized workflows, and large-scale commercialization remain important challenges. Companies need to continuously strengthen automation, computational capabilities, and proprietary data resources to establish sustainable competitive advantages.

Future demand for spatial proteomics and transcriptomics services will increasingly focus on pharmaceutical development, clinical translation, and multi-omics integration. Pharmaceutical companies will increasingly adopt spatial multi-omics technologies for mechanism-of-action studies, immune microenvironment analysis, companion diagnostics, and patient stratification.

Biotechnology companies will leverage specialized CRO services to reduce investment in expensive infrastructure and accelerate innovation pipelines. Research institutions and healthcare organizations will expand applications in oncology, neuroscience, developmental biology, and complex disease research.

As spatial biology becomes a fundamental infrastructure for modern life sciences, service providers with global delivery capabilities, advanced technology platforms, and powerful data analytics capabilities will capture significant market opportunities.

This report delivers a comprehensive overview of the global Spatial Proteomics and Transcriptomics Services market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Spatial Proteomics and Transcriptomics Services. The Spatial Proteomics and Transcriptomics Services market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Spatial Proteomics and Transcriptomics Services market comprehensively. Regional market sizes by Type, by Application, by End User, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Spatial Proteomics and Transcriptomics Services manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

MARKET SEGMENTATION

By Company

Standard Biotools
Bruker Spatial Biology
BostonGene
CellCarta
APTBIO
Vizgen
PTM BIO
Crown Bioscience
Biodesix
BGI Genomics
Shanghai OE Biotech
Westlake Omics
MRM Proteomics
Shanghai Bioprofile
Creative Proteomics
MtoZ-Biolabs
Lc-Bio Technologies
Labcorp
Precision Biomarker Laboratories (PBL)
Metware Biotechnology
Cosmos Wisdom
MS Bioworks
Quanterix
CD Genomics
Discovery Life Sciences
Syncell
Illumina
Psomagen
GENEWIZ (Azenta Life Sciences)
Novogene
Creative Bioarray
SeqMatic

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Spatial Proteomics Services
Spatial Transcriptomics Services

Segment by Application

Clinical Diagnostics
Drug Discovery
Others

Segment by Category

Universities and Research Institutes
Hospitals
Pharmaceutical Companies
Others

Segment by Division

Oncology
Cardiovascular
Agriculture
Neuroscience
Other

biaoTi CHAPTER OUTLINE

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by End User, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.

Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.

Chapter 3: Provides a detailed view of the competitive landscape for Spatial Proteomics and Transcriptomics Services companies, covering revenue share, development plans, and mergers and acquisitions.

Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.

Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.

Chapter 12: Key findings and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Spatial Proteomics Services

1.2.3 Spatial Transcriptomics Services

1.3 Market by End User

1.3.1 Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by End User: 2021 vs 2025 vs 2032

1.3.2 Universities and Research Institutes

1.3.3 Hospitals

1.3.4 Pharmaceutical Companies

1.3.5 Others

1.4 Market by Research Areas

1.4.1 Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Research Areas: 2021 vs 2025 vs 2032

1.4.2 Oncology

1.4.3 Cardiovascular

1.4.4 Agriculture

1.4.5 Neuroscience

1.4.6 Other

1.5 Market by Application

1.5.1 Global Spatial Proteomics and Transcriptomics Services Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Clinical Diagnostics

1.5.3 Drug Discovery

1.5.4 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Spatial Proteomics and Transcriptomics Services Market Perspective (2021–2032)

2.2 Global Spatial Proteomics and Transcriptomics Services Growth Trends by Region

2.2.1 Global Spatial Proteomics and Transcriptomics Services Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Spatial Proteomics and Transcriptomics Services Historic Market Size by Region (2021–2026)

2.2.3 Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Region (2027–2032)

2.3 Spatial Proteomics and Transcriptomics Services Market Dynamics

2.3.1 Spatial Proteomics and Transcriptomics Services Industry Trends

2.3.2 Spatial Proteomics and Transcriptomics Services Market Drivers

2.3.3 Spatial Proteomics and Transcriptomics Services Market Challenges

2.3.4 Spatial Proteomics and Transcriptomics Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Spatial Proteomics and Transcriptomics Services Players by Revenue

3.1.1 Global Top Spatial Proteomics and Transcriptomics Services Players by Revenue (2021–2026)

3.1.2 Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Players (2021–2026)

3.2 Global Top Spatial Proteomics and Transcriptomics Services Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Spatial Proteomics and Transcriptomics Services Revenue

3.4 Global Spatial Proteomics and Transcriptomics Services Market Concentration Ratio

3.4.1 Global Spatial Proteomics and Transcriptomics Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Spatial Proteomics and Transcriptomics Services Revenue in 2025

3.5 Global Key Players of Spatial Proteomics and Transcriptomics Services Head Offices and Areas Served

3.6 Global Key Players of Spatial Proteomics and Transcriptomics Services, Products and Applications

3.7 Global Key Players of Spatial Proteomics and Transcriptomics Services, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Spatial Proteomics and Transcriptomics Services Breakdown Data by Type

4.1 Global Spatial Proteomics and Transcriptomics Services Historic Market Size by Type (2021–2026)

4.2 Global Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Type (2027–2032)

5 Spatial Proteomics and Transcriptomics Services Breakdown Data by Application

5.1 Global Spatial Proteomics and Transcriptomics Services Historic Market Size by Application (2021–2026)

5.2 Global Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Spatial Proteomics and Transcriptomics Services Market Size (2021–2032)

6.2 North America Spatial Proteomics and Transcriptomics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Spatial Proteomics and Transcriptomics Services Market Size by Country (2021–2026)

6.4 North America Spatial Proteomics and Transcriptomics Services Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Spatial Proteomics and Transcriptomics Services Market Size (2021–2032)

7.2 Europe Spatial Proteomics and Transcriptomics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Spatial Proteomics and Transcriptomics Services Market Size by Country (2021–2026)

7.4 Europe Spatial Proteomics and Transcriptomics Services Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size (2021–2032)

8.2 Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size by Region (2021–2026)

8.4 Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Spatial Proteomics and Transcriptomics Services Market Size (2021–2032)

9.2 Latin America Spatial Proteomics and Transcriptomics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Spatial Proteomics and Transcriptomics Services Market Size by Country (2021–2026)

9.4 Latin America Spatial Proteomics and Transcriptomics Services Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size (2021–2032)

10.2 Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size by Country (2021–2026)

10.4 Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Standard Biotools

11.1.1 Standard Biotools Company Details

11.1.2 Standard Biotools Business Overview

11.1.3 Standard Biotools Spatial Proteomics and Transcriptomics Services Introduction

11.1.4 Standard Biotools Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.1.5 Standard Biotools Recent Development

11.2 Bruker Spatial Biology

11.2.1 Bruker Spatial Biology Company Details

11.2.2 Bruker Spatial Biology Business Overview

11.2.3 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Introduction

11.2.4 Bruker Spatial Biology Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.2.5 Bruker Spatial Biology Recent Development

11.3 BostonGene

11.3.1 BostonGene Company Details

11.3.2 BostonGene Business Overview

11.3.3 BostonGene Spatial Proteomics and Transcriptomics Services Introduction

11.3.4 BostonGene Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.3.5 BostonGene Recent Development

11.4 CellCarta

11.4.1 CellCarta Company Details

11.4.2 CellCarta Business Overview

11.4.3 CellCarta Spatial Proteomics and Transcriptomics Services Introduction

11.4.4 CellCarta Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.4.5 CellCarta Recent Development

11.5 APTBIO

11.5.1 APTBIO Company Details

11.5.2 APTBIO Business Overview

11.5.3 APTBIO Spatial Proteomics and Transcriptomics Services Introduction

11.5.4 APTBIO Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.5.5 APTBIO Recent Development

11.6 Vizgen

11.6.1 Vizgen Company Details

11.6.2 Vizgen Business Overview

11.6.3 Vizgen Spatial Proteomics and Transcriptomics Services Introduction

11.6.4 Vizgen Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.6.5 Vizgen Recent Development

11.7 PTM BIO

11.7.1 PTM BIO Company Details

11.7.2 PTM BIO Business Overview

11.7.3 PTM BIO Spatial Proteomics and Transcriptomics Services Introduction

11.7.4 PTM BIO Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.7.5 PTM BIO Recent Development

11.8 Crown Bioscience

11.8.1 Crown Bioscience Company Details

11.8.2 Crown Bioscience Business Overview

11.8.3 Crown Bioscience Spatial Proteomics and Transcriptomics Services Introduction

11.8.4 Crown Bioscience Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.8.5 Crown Bioscience Recent Development

11.9 Biodesix

11.9.1 Biodesix Company Details

11.9.2 Biodesix Business Overview

11.9.3 Biodesix Spatial Proteomics and Transcriptomics Services Introduction

11.9.4 Biodesix Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.9.5 Biodesix Recent Development

11.10 BGI Genomics

11.10.1 BGI Genomics Company Details

11.10.2 BGI Genomics Business Overview

11.10.3 BGI Genomics Spatial Proteomics and Transcriptomics Services Introduction

11.10.4 BGI Genomics Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.10.5 BGI Genomics Recent Development

11.11 Shanghai OE Biotech

11.11.1 Shanghai OE Biotech Company Details

11.11.2 Shanghai OE Biotech Business Overview

11.11.3 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Introduction

11.11.4 Shanghai OE Biotech Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.11.5 Shanghai OE Biotech Recent Development

11.12 Westlake Omics

11.12.1 Westlake Omics Company Details

11.12.2 Westlake Omics Business Overview

11.12.3 Westlake Omics Spatial Proteomics and Transcriptomics Services Introduction

11.12.4 Westlake Omics Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.12.5 Westlake Omics Recent Development

11.13 MRM Proteomics

11.13.1 MRM Proteomics Company Details

11.13.2 MRM Proteomics Business Overview

11.13.3 MRM Proteomics Spatial Proteomics and Transcriptomics Services Introduction

11.13.4 MRM Proteomics Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.13.5 MRM Proteomics Recent Development

11.14 Shanghai Bioprofile

11.14.1 Shanghai Bioprofile Company Details

11.14.2 Shanghai Bioprofile Business Overview

11.14.3 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Introduction

11.14.4 Shanghai Bioprofile Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.14.5 Shanghai Bioprofile Recent Development

11.15 Creative Proteomics

11.15.1 Creative Proteomics Company Details

11.15.2 Creative Proteomics Business Overview

11.15.3 Creative Proteomics Spatial Proteomics and Transcriptomics Services Introduction

11.15.4 Creative Proteomics Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.15.5 Creative Proteomics Recent Development

11.16 MtoZ-Biolabs

11.16.1 MtoZ-Biolabs Company Details

11.16.2 MtoZ-Biolabs Business Overview

11.16.3 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Introduction

11.16.4 MtoZ-Biolabs Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.16.5 MtoZ-Biolabs Recent Development

11.17 Lc-Bio Technologies

11.17.1 Lc-Bio Technologies Company Details

11.17.2 Lc-Bio Technologies Business Overview

11.17.3 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Introduction

11.17.4 Lc-Bio Technologies Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.17.5 Lc-Bio Technologies Recent Development

11.18 Labcorp

11.18.1 Labcorp Company Details

11.18.2 Labcorp Business Overview

11.18.3 Labcorp Spatial Proteomics and Transcriptomics Services Introduction

11.18.4 Labcorp Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.18.5 Labcorp Recent Development

11.19 Precision Biomarker Laboratories (PBL)

11.19.1 Precision Biomarker Laboratories (PBL) Company Details

11.19.2 Precision Biomarker Laboratories (PBL) Business Overview

11.19.3 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Introduction

11.19.4 Precision Biomarker Laboratories (PBL) Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.19.5 Precision Biomarker Laboratories (PBL) Recent Development

11.20 Metware Biotechnology

11.20.1 Metware Biotechnology Company Details

11.20.2 Metware Biotechnology Business Overview

11.20.3 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Introduction

11.20.4 Metware Biotechnology Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.20.5 Metware Biotechnology Recent Development

11.21 Cosmos Wisdom

11.21.1 Cosmos Wisdom Company Details

11.21.2 Cosmos Wisdom Business Overview

11.21.3 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Introduction

11.21.4 Cosmos Wisdom Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.21.5 Cosmos Wisdom Recent Development

11.22 MS Bioworks

11.22.1 MS Bioworks Company Details

11.22.2 MS Bioworks Business Overview

11.22.3 MS Bioworks Spatial Proteomics and Transcriptomics Services Introduction

11.22.4 MS Bioworks Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.22.5 MS Bioworks Recent Development

11.23 Quanterix

11.23.1 Quanterix Company Details

11.23.2 Quanterix Business Overview

11.23.3 Quanterix Spatial Proteomics and Transcriptomics Services Introduction

11.23.4 Quanterix Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.23.5 Quanterix Recent Development

11.24 CD Genomics

11.24.1 CD Genomics Company Details

11.24.2 CD Genomics Business Overview

11.24.3 CD Genomics Spatial Proteomics and Transcriptomics Services Introduction

11.24.4 CD Genomics Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.24.5 CD Genomics Recent Development

11.25 Discovery Life Sciences

11.25.1 Discovery Life Sciences Company Details

11.25.2 Discovery Life Sciences Business Overview

11.25.3 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Introduction

11.25.4 Discovery Life Sciences Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.25.5 Discovery Life Sciences Recent Development

11.26 Syncell

11.26.1 Syncell Company Details

11.26.2 Syncell Business Overview

11.26.3 Syncell Spatial Proteomics and Transcriptomics Services Introduction

11.26.4 Syncell Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.26.5 Syncell Recent Development

11.27 Illumina

11.27.1 Illumina Company Details

11.27.2 Illumina Business Overview

11.27.3 Illumina Spatial Proteomics and Transcriptomics Services Introduction

11.27.4 Illumina Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.27.5 Illumina Recent Development

11.28 Psomagen

11.28.1 Psomagen Company Details

11.28.2 Psomagen Business Overview

11.28.3 Psomagen Spatial Proteomics and Transcriptomics Services Introduction

11.28.4 Psomagen Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.28.5 Psomagen Recent Development

11.29 GENEWIZ (Azenta Life Sciences)

11.29.1 GENEWIZ (Azenta Life Sciences) Company Details

11.29.2 GENEWIZ (Azenta Life Sciences) Business Overview

11.29.3 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Introduction

11.29.4 GENEWIZ (Azenta Life Sciences) Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.29.5 GENEWIZ (Azenta Life Sciences) Recent Development

11.30 Novogene

11.30.1 Novogene Company Details

11.30.2 Novogene Business Overview

11.30.3 Novogene Spatial Proteomics and Transcriptomics Services Introduction

11.30.4 Novogene Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.30.5 Novogene Recent Development

11.31 Creative Bioarray

11.31.1 Creative Bioarray Company Details

11.31.2 Creative Bioarray Business Overview

11.31.3 Creative Bioarray Spatial Proteomics and Transcriptomics Services Introduction

11.31.4 Creative Bioarray Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.31.5 Creative Bioarray Recent Development

11.32 SeqMatic

11.32.1 SeqMatic Company Details

11.32.2 SeqMatic Business Overview

11.32.3 SeqMatic Spatial Proteomics and Transcriptomics Services Introduction

11.32.4 SeqMatic Revenue in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

11.32.5 SeqMatic Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Spatial Proteomics Services

Table 3. Key Players of Spatial Transcriptomics Services

Table 4. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by End User (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of Universities and Research Institutes

Table 6. Key Players of Hospitals

Table 7. Key Players of Pharmaceutical Companies

Table 8. Key Players of Others

Table 9. Global Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Research Areas (US$ Million): 2021 vs 2025 vs 2032

Table 10. Key Players of Oncology

Table 11. Key Players of Cardiovascular

Table 12. Key Players of Agriculture

Table 13. Key Players of Neuroscience

Table 14. Key Players of Other

Table 15. Global Spatial Proteomics and Transcriptomics Services Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Spatial Proteomics and Transcriptomics Services Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Spatial Proteomics and Transcriptomics Services Market Size by Region (US$ Million), 2021–2026

Table 18. Global Spatial Proteomics and Transcriptomics Services Market Share by Region (2021–2026)

Table 19. Global Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Region (US$ Million), 2027–2032

Table 20. Global Spatial Proteomics and Transcriptomics Services Market Share by Region (2027–2032)

Table 21. Spatial Proteomics and Transcriptomics Services Market Trends

Table 22. Spatial Proteomics and Transcriptomics Services Market Drivers

Table 23. Spatial Proteomics and Transcriptomics Services Market Challenges

Table 24. Spatial Proteomics and Transcriptomics Services Market Restraints

Table 25. Global Spatial Proteomics and Transcriptomics Services Revenue by Players (US$ Million), 2021–2026

Table 26. Global Spatial Proteomics and Transcriptomics Services Market Share by Players (2021–2026)

Table 27. Global Top Spatial Proteomics and Transcriptomics Services Players by Tier (Tier 1, Tier 2, and Tier 3), based on Spatial Proteomics and Transcriptomics Services Revenue, 2025

Table 28. Ranking of Global Top Spatial Proteomics and Transcriptomics Services Companies by Revenue (US$ Million) in 2025

Table 29. Global 5 Largest Players Market Share by Spatial Proteomics and Transcriptomics Services Revenue (CR5 and HHI), 2021–2026

Table 30. Global Key Players of Spatial Proteomics and Transcriptomics Services, Headquarters and Area Served

Table 31. Global Key Players of Spatial Proteomics and Transcriptomics Services, Products and Applications

Table 32. Global Key Players of Spatial Proteomics and Transcriptomics Services, Date of General Availability (GA)

Table 33. Mergers and Acquisitions, Expansion Plans

Table 34. Global Spatial Proteomics and Transcriptomics Services Market Size by Type (US$ Million), 2021–2026

Table 35. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2021–2026)

Table 36. Global Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Type (US$ Million), 2027–2032

Table 37. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Type (2027–2032)

Table 38. Global Spatial Proteomics and Transcriptomics Services Market Size by Application (US$ Million), 2021–2026

Table 39. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2021–2026)

Table 40. Global Spatial Proteomics and Transcriptomics Services Forecasted Market Size by Application (US$ Million), 2027–2032

Table 41. Global Spatial Proteomics and Transcriptomics Services Revenue Market Share by Application (2027–2032)

Table 42. North America Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. North America Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2021–2026

Table 44. North America Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2027–2032

Table 45. Europe Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Europe Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2021–2026

Table 47. Europe Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2027–2032

Table 48. Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 49. Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size by Region (US$ Million), 2021–2026

Table 50. Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size by Region (US$ Million), 2027–2032

Table 51. Latin America Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Latin America Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2021–2026

Table 53. Latin America Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2027–2032

Table 54. Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2021–2026

Table 56. Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size by Country (US$ Million), 2027–2032

Table 57. Standard Biotools Company Details

Table 58. Standard Biotools Business Overview

Table 59. Standard Biotools Spatial Proteomics and Transcriptomics Services Product

Table 60. Standard Biotools Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 61. Standard Biotools Recent Development

Table 62. Bruker Spatial Biology Company Details

Table 63. Bruker Spatial Biology Business Overview

Table 64. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Product

Table 65. Bruker Spatial Biology Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 66. Bruker Spatial Biology Recent Development

Table 67. BostonGene Company Details

Table 68. BostonGene Business Overview

Table 69. BostonGene Spatial Proteomics and Transcriptomics Services Product

Table 70. BostonGene Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 71. BostonGene Recent Development

Table 72. CellCarta Company Details

Table 73. CellCarta Business Overview

Table 74. CellCarta Spatial Proteomics and Transcriptomics Services Product

Table 75. CellCarta Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 76. CellCarta Recent Development

Table 77. APTBIO Company Details

Table 78. APTBIO Business Overview

Table 79. APTBIO Spatial Proteomics and Transcriptomics Services Product

Table 80. APTBIO Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 81. APTBIO Recent Development

Table 82. Vizgen Company Details

Table 83. Vizgen Business Overview

Table 84. Vizgen Spatial Proteomics and Transcriptomics Services Product

Table 85. Vizgen Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 86. Vizgen Recent Development

Table 87. PTM BIO Company Details

Table 88. PTM BIO Business Overview

Table 89. PTM BIO Spatial Proteomics and Transcriptomics Services Product

Table 90. PTM BIO Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 91. PTM BIO Recent Development

Table 92. Crown Bioscience Company Details

Table 93. Crown Bioscience Business Overview

Table 94. Crown Bioscience Spatial Proteomics and Transcriptomics Services Product

Table 95. Crown Bioscience Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 96. Crown Bioscience Recent Development

Table 97. Biodesix Company Details

Table 98. Biodesix Business Overview

Table 99. Biodesix Spatial Proteomics and Transcriptomics Services Product

Table 100. Biodesix Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 101. Biodesix Recent Development

Table 102. BGI Genomics Company Details

Table 103. BGI Genomics Business Overview

Table 104. BGI Genomics Spatial Proteomics and Transcriptomics Services Product

Table 105. BGI Genomics Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 106. BGI Genomics Recent Development

Table 107. Shanghai OE Biotech Company Details

Table 108. Shanghai OE Biotech Business Overview

Table 109. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Product

Table 110. Shanghai OE Biotech Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 111. Shanghai OE Biotech Recent Development

Table 112. Westlake Omics Company Details

Table 113. Westlake Omics Business Overview

Table 114. Westlake Omics Spatial Proteomics and Transcriptomics Services Product

Table 115. Westlake Omics Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 116. Westlake Omics Recent Development

Table 117. MRM Proteomics Company Details

Table 118. MRM Proteomics Business Overview

Table 119. MRM Proteomics Spatial Proteomics and Transcriptomics Services Product

Table 120. MRM Proteomics Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 121. MRM Proteomics Recent Development

Table 122. Shanghai Bioprofile Company Details

Table 123. Shanghai Bioprofile Business Overview

Table 124. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Product

Table 125. Shanghai Bioprofile Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 126. Shanghai Bioprofile Recent Development

Table 127. Creative Proteomics Company Details

Table 128. Creative Proteomics Business Overview

Table 129. Creative Proteomics Spatial Proteomics and Transcriptomics Services Product

Table 130. Creative Proteomics Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 131. Creative Proteomics Recent Development

Table 132. MtoZ-Biolabs Company Details

Table 133. MtoZ-Biolabs Business Overview

Table 134. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Product

Table 135. MtoZ-Biolabs Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 136. MtoZ-Biolabs Recent Development

Table 137. Lc-Bio Technologies Company Details

Table 138. Lc-Bio Technologies Business Overview

Table 139. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Product

Table 140. Lc-Bio Technologies Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 141. Lc-Bio Technologies Recent Development

Table 142. Labcorp Company Details

Table 143. Labcorp Business Overview

Table 144. Labcorp Spatial Proteomics and Transcriptomics Services Product

Table 145. Labcorp Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 146. Labcorp Recent Development

Table 147. Precision Biomarker Laboratories (PBL) Company Details

Table 148. Precision Biomarker Laboratories (PBL) Business Overview

Table 149. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Product

Table 150. Precision Biomarker Laboratories (PBL) Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 151. Precision Biomarker Laboratories (PBL) Recent Development

Table 152. Metware Biotechnology Company Details

Table 153. Metware Biotechnology Business Overview

Table 154. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Product

Table 155. Metware Biotechnology Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 156. Metware Biotechnology Recent Development

Table 157. Cosmos Wisdom Company Details

Table 158. Cosmos Wisdom Business Overview

Table 159. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Product

Table 160. Cosmos Wisdom Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 161. Cosmos Wisdom Recent Development

Table 162. MS Bioworks Company Details

Table 163. MS Bioworks Business Overview

Table 164. MS Bioworks Spatial Proteomics and Transcriptomics Services Product

Table 165. MS Bioworks Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 166. MS Bioworks Recent Development

Table 167. Quanterix Company Details

Table 168. Quanterix Business Overview

Table 169. Quanterix Spatial Proteomics and Transcriptomics Services Product

Table 170. Quanterix Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 171. Quanterix Recent Development

Table 172. CD Genomics Company Details

Table 173. CD Genomics Business Overview

Table 174. CD Genomics Spatial Proteomics and Transcriptomics Services Product

Table 175. CD Genomics Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 176. CD Genomics Recent Development

Table 177. Discovery Life Sciences Company Details

Table 178. Discovery Life Sciences Business Overview

Table 179. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Product

Table 180. Discovery Life Sciences Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 181. Discovery Life Sciences Recent Development

Table 182. Syncell Company Details

Table 183. Syncell Business Overview

Table 184. Syncell Spatial Proteomics and Transcriptomics Services Product

Table 185. Syncell Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 186. Syncell Recent Development

Table 187. Illumina Company Details

Table 188. Illumina Business Overview

Table 189. Illumina Spatial Proteomics and Transcriptomics Services Product

Table 190. Illumina Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 191. Illumina Recent Development

Table 192. Psomagen Company Details

Table 193. Psomagen Business Overview

Table 194. Psomagen Spatial Proteomics and Transcriptomics Services Product

Table 195. Psomagen Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 196. Psomagen Recent Development

Table 197. GENEWIZ (Azenta Life Sciences) Company Details

Table 198. GENEWIZ (Azenta Life Sciences) Business Overview

Table 199. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Product

Table 200. GENEWIZ (Azenta Life Sciences) Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 201. GENEWIZ (Azenta Life Sciences) Recent Development

Table 202. Novogene Company Details

Table 203. Novogene Business Overview

Table 204. Novogene Spatial Proteomics and Transcriptomics Services Product

Table 205. Novogene Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 206. Novogene Recent Development

Table 207. Creative Bioarray Company Details

Table 208. Creative Bioarray Business Overview

Table 209. Creative Bioarray Spatial Proteomics and Transcriptomics Services Product

Table 210. Creative Bioarray Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 211. Creative Bioarray Recent Development

Table 212. SeqMatic Company Details

Table 213. SeqMatic Business Overview

Table 214. SeqMatic Spatial Proteomics and Transcriptomics Services Product

Table 215. SeqMatic Revenue in Spatial Proteomics and Transcriptomics Services Business (US$ Million), 2021–2026

Table 216. SeqMatic Recent Development

Table 217. Research Programs/Design for This Report

Table 218. Key Data Information from Secondary Sources

Table 219. Key Data Information from Primary Sources

Table 220. Authors List of This Report

List of Figures

Figure 1. Spatial Proteomics and Transcriptomics Services Picture

Figure 2. Global Spatial Proteomics and Transcriptomics Services Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Spatial Proteomics and Transcriptomics Services Market Share by Type: 2025 vs 2032

Figure 4. Spatial Proteomics Services Features

Figure 5. Spatial Transcriptomics Services Features

Figure 6. Global Spatial Proteomics and Transcriptomics Services Market Size Comparison by End User (US$ Million), 2021–2032

Figure 7. Universities and Research Institutes Features

Figure 8. Hospitals Features

Figure 9. Pharmaceutical Companies Features

Figure 10. Others Features

Figure 11. Global Spatial Proteomics and Transcriptomics Services Market Size Comparison by Research Areas (US$ Million), 2021–2032

Figure 12. Oncology Features

Figure 13. Cardiovascular Features

Figure 14. Agriculture Features

Figure 15. Neuroscience Features

Figure 16. Other Features

Figure 17. Global Spatial Proteomics and Transcriptomics Services Market Size by Application (US$ Million), 2021–2032

Figure 18. Global Spatial Proteomics and Transcriptomics Services Market Share by Application: 2025 vs 2032

Figure 19. Clinical Diagnostics Case Studies

Figure 20. Drug Discovery Case Studies

Figure 21. Others Case Studies

Figure 22. Spatial Proteomics and Transcriptomics Services Report Years Considered

Figure 23. Global Spatial Proteomics and Transcriptomics Services Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 24. Global Spatial Proteomics and Transcriptomics Services Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 25. Global Spatial Proteomics and Transcriptomics Services Market Share by Region: 2025 vs 2032

Figure 26. Global Spatial Proteomics and Transcriptomics Services Market Share by Players in 2025

Figure 27. Global Spatial Proteomics and Transcriptomics Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 28. The Top 10 and 5 Players Market Share by Spatial Proteomics and Transcriptomics Services Revenue in 2025

Figure 29. North America Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. North America Spatial Proteomics and Transcriptomics Services Market Share by Country (2021–2032)

Figure 31. United States Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Canada Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Europe Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Spatial Proteomics and Transcriptomics Services Market Share by Country (2021–2032)

Figure 35. Germany Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. France Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. U.K. Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Italy Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Russia Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Ireland Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Spatial Proteomics and Transcriptomics Services Market Share by Region (2021–2032)

Figure 43. China Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Japan Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. South Korea Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Southeast Asia Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. India Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Australia & New Zealand Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Latin America Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Spatial Proteomics and Transcriptomics Services Market Share by Country (2021–2032)

Figure 51. Mexico Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Brazil Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Spatial Proteomics and Transcriptomics Services Market Share by Country (2021–2032)

Figure 55. Israel Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. Saudi Arabia Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. UAE Spatial Proteomics and Transcriptomics Services Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. Standard Biotools Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 59. Bruker Spatial Biology Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 60. BostonGene Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 61. CellCarta Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 62. APTBIO Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 63. Vizgen Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 64. PTM BIO Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 65. Crown Bioscience Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 66. Biodesix Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 67. BGI Genomics Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 68. Shanghai OE Biotech Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 69. Westlake Omics Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 70. MRM Proteomics Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 71. Shanghai Bioprofile Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 72. Creative Proteomics Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 73. MtoZ-Biolabs Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 74. Lc-Bio Technologies Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 75. Labcorp Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 76. Precision Biomarker Laboratories (PBL) Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 77. Metware Biotechnology Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 78. Cosmos Wisdom Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 79. MS Bioworks Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 80. Quanterix Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 81. CD Genomics Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 82. Discovery Life Sciences Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 83. Syncell Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 84. Illumina Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 85. Psomagen Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 86. GENEWIZ (Azenta Life Sciences) Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 87. Novogene Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 88. Creative Bioarray Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 89. SeqMatic Revenue Growth Rate in Spatial Proteomics and Transcriptomics Services Business (2021–2026)

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What was the global market size of Spatial Proteomics and Transcriptomics Services in 2026? zhanKai

The global market size of Spatial Proteomics and Transcriptomics Services in 2026 was 210 Million USD.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Spatial Proteomics and Transcriptomics Services market? shouQi

What was the global market size of Spatial Proteomics and Transcriptomics Services in 2032? shouQi

What is the annual compound growth rate of the global Spatial Proteomics and Transcriptomics Services market size from 2026 to 2032? shouQi

Related Reports

Global Spatial Proteomics and Transcriptomics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Proteomics and Transcriptomics Services market size was US$ 188 million in 2025 and is forecast to reach a readjusted size of US$ 470 million by 2032 with a CAGR of 14.4% during the forecast period 2026-2032.
Published Date: 2026-07-17
Pages: 192
USD 4250.00
(Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Proteomics and Transcriptomics Services market is projected to grow from US$ 188 million in 2025 to US$ 470 million by 2032, at a CAGR of 14.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-07-17
Pages: 210
USD 4900.00
(Single User License)
Spatial Proteomics and Transcriptomics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Proteomics and Transcriptomics Services was estimated to be worth US$ 188 million in 2025 and is projected to reach US$ 470 million, growing at a CAGR of 14.4% from 2026 to 2032.
Published Date: 2026-07-17
Pages: 188
USD 3950.00
(Single User License)

Global Spatial Proteomics and Transcriptomics Services Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Spatial Proteomics and Transcriptomics Services market size was US$ 188 million in 2025 and is forecast to reach a readjusted size of US$ 470 million by 2032 with a CAGR of 14.4% during the forecast period 2026-2032.
Published: 2026-07-17
Pages: 192
USD 4250.00 (Single User License)
Global Spatial Proteomics and Transcriptomics Services Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Spatial Proteomics and Transcriptomics Services market is projected to grow from US$ 188 million in 2025 to US$ 470 million by 2032, at a CAGR of 14.4% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-07-17
Pages: 210
USD 4900.00 (Single User License)
Spatial Proteomics and Transcriptomics Services - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Spatial Proteomics and Transcriptomics Services was estimated to be worth US$ 188 million in 2025 and is projected to reach US$ 470 million, growing at a CAGR of 14.4% from 2026 to 2032.
Published: 2026-07-17
Pages: 188
USD 3950.00 (Single User License)